This report studies the global Veterinary Vaccine market status and forecast, categorizes the global Veterinary Vaccine market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).
An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
The classification of Veterinary Vaccine Adjuvants includes Oral, Subcutaneous, Intramuscular and Others. And the proportion of Intramuscular in 2017 is about 41.5%. The Subcutaneous in 2016 is about 23.4%.
Veterinary Vaccine Adjuvants is widely sales for Livestock Vaccines, Companion Animals Vaccines. The most proportion of Veterinary Vaccine Adjuvants is used for Livestock Vaccines, and the consumption proportion is about 88.4% in 2017.
Europe is the largest consumption place, with a consumption market share nearly 43.3% in 2017. Following Europe, North America is the second largest consumption place with the consumption market share of 26%; China is also an important sales region for the Veterinary Vaccine Adjuvants.
Market competition is intense. SEPPIC, SDA BIO, Brenntag Biosector, SPI Pharma, etc. are the leaders of the industry. They hold the key technologies and patents, with high-end customers. They have formed global market channel of the industry. However, with the future expanding market, there will be more manufacturers in the future.
The global Veterinary Vaccine market is valued at 260 million US$ in 2017 and will reach 1650 million US$ by the end of 2025, growing at a CAGR of 26.0% during 2018-2025.
The major players covered in this report
SEPPIC
SDA BIO
Brenntag Biosector
SPI Pharma
MVP Laboratories
Zhuoyue
Zhiju Bio
...
Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India
We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Oral
Subcutaneous
Intramuscular
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Livestock Vaccines
Companion Animals Vaccines
The study objectives of this report are:
To analyze and study the global Veterinary Vaccine sales, value, status (2013-2017) and forecast (2018-2025);
To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
Focuses on the key Veterinary Vaccine players, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Veterinary Vaccine are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Veterinary Vaccine Manufacturers
Veterinary Vaccine Distributors/Traders/Wholesalers
Veterinary Vaccine Subcomponent Manufacturers
Industry Association
Downstream Vendors
Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Veterinary Vaccine market, by end-use.
Detailed analysis and profiles of additional market players.